Intranasal AAV9-PHP.eB gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intranasal AAV9-PHP.eB gene therapy, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)